Contribution Agreements in the Health Care Equipment & Supplies Industry
16 Contracts & Agreements
- AdvanSource Biomaterials Corp (5 contracts)
- BIOLIFE SOLUTIONS INC (3)
- CESCA THERAPEUTICS INC. (1)
- Chromocell Therapeutics Corp (2)
- Invea Therapeutics, Inc (1)
- NeuroMetrix, Inc. (1)
- Salona Global Medical Device Corp (1)
- SECOND SIGHT MEDICAL PRODUCTS INC (1)
- WOUND MANAGEMENT TECHNOLOGIES, INC. (1)
- Contribution Agreement dated February 23, 2023 among Nordicus Partners Corporation, Nordicus Partners A/S, GK Partners ApS, Henrik Rouf and Life Science Power House ApS (AdvanSource Biomaterials Corp, Filed With SEC on December 6, 2023)
- Contribution Agreement dated February 23, 2023 among Nordicus Partners Corporation, Nordicus Partners A/S, GK Partners ApS, Henrik Rouf and Life Science Power House ApS (AdvanSource Biomaterials Corp, Filed With SEC on November 27, 2023)
- Contribution Agreement dated February 23, 2023 among Nordicus Partners Corporation, Nordicus Partners A/S, GK Partners ApS, Henrik Rouf and Life Science Power House ApS (AdvanSource Biomaterials Corp, Filed With SEC on November 13, 2023)
- Contribution Agreement dated February 23, 2023 among Nordicus Partners Corporation, Nordicus Partners A/S, GK Partners ApS, Henrik Rouf and Life Science Power House ApS (AdvanSource Biomaterials Corp, Filed With SEC on October 24, 2023)
- Asset Contribution Agreement, between InveniAI LLC and the Registrant, dated November 24, 2021 (Invea Therapeutics, Inc, Filed With SEC on October 20, 2023)
- Side Letter to Contribution Agreement (Chromocell Therapeutics Corp, Filed With SEC on September 1, 2023)
- Contribution Agreement, dated February 23, 2023, by and among the Company, Nordicus, GK Partners ApS, Henrik Rouf and Life Science Power House ApS (AdvanSource Biomaterials Corp, Filed With SEC on March 1, 2023)
- Contribution Agreement (Chromocell Therapeutics Corp, Filed With SEC on January 20, 2023)
- Contribution Agreement dated as of November 29, 2021 by and among the Company, ALG Health Plus, LLC, Adam Harmon, ALG-Health LLC and other the parties named therein (Salona Global Medical Device Corp, Filed With SEC on December 3, 2021)
- Form of Contribution Agreement, by and between Second Sight and Pixium (SECOND SIGHT MEDICAL PRODUCTS INC, Filed With SEC on January 6, 2021)
- Contribution Agreement, dated November 22, 2019, between ThermoGenesis Holdings, Inc. and ImmuneCyte Life Sciences Inc (CESCA THERAPEUTICS INC., Filed With SEC on November 27, 2019)
- Contribution Agreement dated August 27, 2018 between Wound Care Innovations, LLC and CGI Cellerate RX, LLC (WOUND MANAGEMENT TECHNOLOGIES, INC., Filed With SEC on November 14, 2018)
- Amendment No. 1 to Contribution Agreement dated January 22, 2018 by and between the Company, Savsu Technologies, LLC and biologistex CCM, LLC (BIOLIFE SOLUTIONS INC, Filed With SEC on March 9, 2018)
- Amendment No. 1 to Contribution Agreement dated January 22, 2018 by and between the Company, Savsu Technologies, LLC and biologistex CCM, LLC (BIOLIFE SOLUTIONS INC, Filed With SEC on March 9, 2018)
- Contribution Agreement, dated as of December 22, 2017, by and between Quell Intellectual Property Corp., LLC and NeuroMetrix, Inc (NeuroMetrix, Inc., Filed With SEC on February 8, 2018)
- CONTRIBUTION AGREEMENT (BIOLIFE SOLUTIONS INC, Filed With SEC on March 15, 2017)
